■估计2022年肯尼亚某些烟草相关疾病(TRI)的经济成本。
■本研究分两个阶段进行。第一阶段于2021年至2022年之间进行,需要在肯尼亚的4家国家公立转诊医院进行横断面研究。心血管疾病患者,癌症,慢性阻塞性肺疾病,或结核病进行了访谈,以计算与疾病相关的间接和直接医疗费用。基于活动的成本计算方法用于在护理连续过程中获取服务成本。在第二阶段,烟草归因因子被用来估计直接的,间接,和最终的经济成本由于吸烟。
■肯尼亚烟草使用估计的医疗保健费用为396,107,364美元。在研究中包括的TRI中,心肌梗死的医疗费用最高,为158,687,627美元,其次是外周动脉疾病和卒中,医疗费用分别为64,723,181美元和44,746,700美元.所有疾病的主要成本驱动因素是药物成本,占总医疗保健成本的90%以上。疾病造成的生产力损失在148美元至360美元之间,占经济成本的27%至48%。选定的TRI的烟草使用对肯尼亚经济造成的总成本在5.4474亿美元至7.5622亿美元之间。
■烟草相关疾病造成了直接和间接成本的巨大经济负担。这些调查结果强调,需要加强执行《烟草控制框架公约》和《烟草控制法》(2007年)的规定,以促进减少人口中的烟草消费。
UNASSIGNED: To estimate the economic costs of selected tobacco-related illnesses (TRI) in Kenya in 2022.
UNASSIGNED: This study was conducted in 2 phases. Phase 1, conducted between 2021 and 2022, entailed conducting a cross-sectional study conducted in 4 national public referral hospitals in Kenya. Patients with cardiovascular disease, cancer, chronic obstructive pulmonary disease, or tuberculosis were interviewed to compute the indirect and direct medical costs related to the illness. Activity-Based Costing approach was used to capture costs for services along the continuum of care pathway. In the second phase, the Tobacco Attributable Factor was used to estimate the direct, indirect, and ultimately economic cost due to tobacco smoking.
UNASSIGNED: The estimated health care cost attributed to tobacco use in Kenya is US$396,107,364. Among TRIs included in the study, myocardial infarction had the highest health care cost at US$158,687,627, followed by peripheral arterial disease and stroke with health care cost of US$64,723,181 and US$44,746,700 respectively. The main cost driver across all the illnesses is the cost for medication accounting for over 90% of the total health care cost. The productivity losses from the diseases ranged between US$148 to US$360 and accounted for 27% to 48% of the economic costs. The total cost attributable to tobacco use to Kenya\'s economy for the selected TRIs was between US$544.74 million and US$756.22 million.
UNASSIGNED: Tobacco related illnesses impose a significant economic burden as reported for direct and indirect costs. These findings underscore the need for strengthened implementation of the provision of the Framework Convention on Tobacco Control and the Tobacco Control Act (2007) to facilitate a reduction in tobacco consumption in the population.